Abstract
INTRODUCTION: Urinary tract endometriosis accounts for 1–2% of surgically diagnosed endometriosis. This challenging condition can lead to significant morbidity, including ureteral obstruction and compromised renal function. Effective management requires a multidisciplinary approach and advanced surgical techniques to ensure complete excision and optimal patient outcomes. OBJECTIVE: The objective of this video is to demonstrate a step-by-step robotic approach for excising complex ureteral and bladder endometriosis. It also aims to demonstrate the technique of ureteroneocystostomy with a psoas hitch and Boari flap for ureteral reconstruction. METHODS: A 44-year-old patient with a history of endometriosis and chronic pelvic pain presented with left hydroureteronephrosis and impaired renal function due to ureteral obstruction. Decision was made to perform a robotic excision of endometriosis. The procedure involved ureterolysis, excision of the bladder and vaginal endometriotic nodules, partial vaginectomy, and ureteroneocystostomy with psoas hitch and Boari flap reconstruction. RESULTS: The complete excision of endometriosis was achieved without complications. The ureteroneocystostomy was successfully performed with a tension-free anastomosis, and the bladder was confirmed to be watertight upon distention. CONCLUSIONS: Robotic excision of complex ureteral and bladder endometriosis, combined with ureteroneocystostomy using a psoas hitch and Boari flap, is a safe and effective approach for managing deep infiltrating urinary tract endometriosis. Key surgical principles, such as complete ureterolysis, adequate hemostasis, precise dissection, and multidisciplinary collaboration, are critical for successful outcomes.
Full text
627 characters
· extracted from
oa-doi-fallback
· click to expand
SGS Abstracts Supplement: Video 9Complex Ureteral, Vaginal, and Bladder Endometriosis Excision and Ureteroneocystostomy: Robotic ApproachBarake, C.1; Moawad, N.2 Author Information 1University of Texas Medical Branch 2University of Florida College of Medicine Financial Disclosure Any of the authors act as a consultant, employee, or shareholder of an industry for: Medtronic, Integra Life Sciences, Womed. Obstetrics & Gynecology 145(5S):p 19S, May 2025. | DOI: 10.1097/AOG.0000000000005851.29 Buy © 2025 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.